APA (7th ed.) Citation

Lehto, N., tiedekunta, M., Sciences, F. o., laitos, B. j. y., Science, D. o. B. a. E., yliopisto, J., & Jyväskylä, U. o. (2020). Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients.

Chicago Style (17th ed.) Citation

Lehto, Niina, Matemaattis-luonnontieteellinen tiedekunta, Faculty of Sciences, Bio- ja ympäristötieteiden laitos, Department of Biological and Environmental Science, Jyväskylän yliopisto, and University of Jyväskylä. Comparison of Two Laboratory Developed PD-L1 Assays with Clinically Approved Ventana SP142 Assay and Prognostic Significance of PD-L1-positivity and Immune Cell Densities in Triple-negative Breast Cancer Patients. 2020.

MLA (9th ed.) Citation

Lehto, Niina, et al. Comparison of Two Laboratory Developed PD-L1 Assays with Clinically Approved Ventana SP142 Assay and Prognostic Significance of PD-L1-positivity and Immune Cell Densities in Triple-negative Breast Cancer Patients. 2020.